EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan

Sujeong Hwang, Yoon Min Jang, Changyoub Han, Hong Ji Song, Ju-Young Shin

Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 1-6

DOI: 10.56142/perm.26.0003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Sujeong Hwang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hwang, S., Jang, Y. M., Han, C., Song, H. J., & Shin, J. (2026). A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan. Journal of Pharmacoepidemiology and Risk Management, 18(1), 1-6. https://doi.org/10.56142/perm.26.0003

Vancouver

Hwang S, Jang YM, Han C, Song HJ, Shin J. A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):1-6. doi:10.56142/perm.26.0003

BibTeX
@article{Hwang2026,
  author = {Hwang, Sujeong and Jang, Yoon Min and Han, Changyoub and Song, Hong Ji and Shin, Ju-Young},
  title = {A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan},
  journal = {Journal of Pharmacoepidemiology and Risk Management},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {1--6},
  doi = {10.56142/perm.26.0003}
}
Kostenlos starten →